NCT07581262

Brief Summary

This study aims to evaluate the effect of health education based on information framing effects on foot ulcer risk perception in patients at high risk of diabetic foot. Study Design: A randomized controlled trial with three groups: Experimental Group 1 (Gain-Framed): Participants received a benefit framing message that emphasized the benefits of standardized foot care in reducing the likelihood and severity of foot ulcers, with an aim to reshape patients' perception of risk. Experimental Group 2 (Loss-Framed):Participants received a loss frame message that emphasized that neglecting foot care would increase the likelihood and severity of foot ulcers. The message was designed to awaken patients' awareness of crisis and risk perception. Control Group (Routine Messaging):Participants received the usual content of care in the endocrinology department without a specific framework. Participants: Diabetic foot patients at high risk from experimental group 1, experimental group 2, and control group 3. Inclusion criteria included adults with a diagnosis of diabetic foot at high risk. Intervention: The Total Study Period consisted of an intervention phase and a follow-up phase. The intervention phase started at the time of enrollment and lasted until the fourth week after discharge. The follow-up period lasted for 3 months. Data on local indicators were collected at baseline/before the intervention (T0), immediately after the intervention (T1), 1 month after the intervention (T2) and 3 months after the intervention (T3). Outcome Measures: Primary Outcomes: Foot ulcer risk perception: Assessed using The Tripartite Model of Risk Perception Scale. Secondary Outcomes: Foot care behavior score: Assessed using The Nottingham Foot Care Assessment Scale; Self-efficacy: Assessed using The Diabetes Self-Efficacy Scale; Intention to delay seeking medical help score:Assessed using the Questionnaire on Intention to Delay Seeking Medical Care for Patients with High-Risk Diabetic Foot; the incidence/recurrence rate of foot ulcers, and various laboratory indicators.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
7mo left

Started May 2026

Shorter than P25 for not_applicable diabetes-mellitus

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
May 2026Dec 2026

First Submitted

Initial submission to the registry

April 28, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 12, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 12, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

April 28, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

diabetes mellitushigh risk footdiabetic foot ulcerrisk perception

Outcome Measures

Primary Outcomes (1)

  • foot ulcer risk perception score

    Assessed using the Chinese version of the Tripartite Model of Risk Perception (TRIRISK) Scale, developed by Ferrer et al. in 2016. The scale consists of 18 items across 3 dimensions: rational perception, emotional perception, and experience perception. A Likert 7-point scoring method (1-7 points) is used. Higher scores indicate a higher individual perception of diabetic foot ulcer risk.

    Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention.

Secondary Outcomes (6)

  • Foot care behavior score

    Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention

  • Diabetes self-efficacy score

    Baseline, at the end of intervention (week 4), and at 1 and 3 months post-intervention.

  • Baseline Demographic and Clinical Characteristics

    Baseline (T0)

  • Medical Help-seeking Delay Intention score

    Baseline (T0), at the end of intervention (T1), and at 1 month (T2) and 3 months (T3) post-intervention.

  • Glycemic Control Indicators

    HbA1c will be measured at baseline (T0) and 3 months post-intervention (T3).

  • +1 more secondary outcomes

Other Outcomes (2)

  • laboratory index

    Baseline (T0) and 3 months post-intervention (T3).

  • DFU Incidence and Recurrence.

    From baseline through the 3-month follow-up.

Study Arms (3)

Experimental Group 1: Gain-Framed

EXPERIMENTAL

Participants will receive a gain-framed health education intervention starting during hospitalization and continuing for 4 weeks post-discharge via WeChat. They will be provided with a gain-framed "High-Risk Foot Protection Manual," educational videos, and peer success stories. For example, a message will state: "Mastering proper foot care helps establish an external protective barrier for your feet, effectively preventing 50% of foot ulcers and maintaining your independent mobility." Participants will also submit foot care photo check-ins via WeChat, receiving gain-framed positive reinforcement regarding their healthy habits.

Behavioral: Gain-Framed

Experimental Group 2: Loss-Framed

EXPERIMENTAL

Participants will receive a loss-framed health education intervention following the same methods (face-to-face and WeChat) as Group 1. They will receive a loss-framed manual, videos, and peer warning stories. An example message will state: "Ignoring proper foot care routines can cause minor wounds to rapidly deteriorate into deep infections, leading to a 19% risk of amputation, loss of mobility, and heavy financial burdens." During their WeChat check-ins, they will receive loss-framed reminders emphasizing the severe risks of neglecting foot care.

Behavioral: Loss-Framed

Control Group: Routine Care

ACTIVE COMPARATOR

Participants will receive standard, neutral health education regarding diabetic foot care without any specific information framing. They will receive standard, neutral endocrinology department routine care without any specific information framework.

Behavioral: Routine Care

Interventions

Gain-FramedBEHAVIORAL

Participants will receive a gain-framed health education intervention starting during hospitalization and continuing for 4 weeks post-discharge via WeChat. They will be provided with a gain-framed "High-Risk Foot Protection Manual," educational videos, and peer success stories. For example, a message will state: "Mastering proper foot care helps establish an external protective barrier for your feet, effectively preventing 50% of foot ulcers and maintaining your independent mobility." Participants will also submit foot care photo check-ins via WeChat, receiving gain-framed positive reinforcement regarding their healthy habits.

Experimental Group 1: Gain-Framed
Loss-FramedBEHAVIORAL

Participants will receive a loss-framed health education intervention following the same methods (face-to-face and WeChat) as Group 1. They will receive a loss-framed manual, videos, and peer warning stories. An example message will state: "Ignoring proper foot care routines can cause minor wounds to rapidly deteriorate into deep infections, leading to a 19% risk of amputation, loss of mobility, and heavy financial burdens." During their WeChat check-ins, they will receive loss-framed reminders emphasizing the severe risks of neglecting foot care.

Experimental Group 2: Loss-Framed
Routine CareBEHAVIORAL

Participants will receive standard, objective health education regarding diabetic foot care without any specific information framing. This includes routine nursing care from the Department of Endocrinology, such as inpatient foot skin assessment, basic hygiene education, and standard hospital discharge guidance. Post-discharge follow-ups will be conducted via telephone or WeChat to monitor recovery and medication adherence according to the hospital's standard protocol.

Control Group: Routine Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old with good communication and cognitive abilities.
  • Meet the World Health Organization (WHO) diagnostic criteria for Type 1 or Type 2 Diabetes Mellitus.
  • Meet the diagnostic criteria for high-risk diabetic foot according to the International Working Group on the Diabetic Foot (IWGDF) 2023 standards.
  • Proficient in the use of a smartphone and related applications (e.g., WeChat).
  • Voluntarily participate in the study and provide signed informed consent.

You may not qualify if:

  • Patients with impaired consciousness, severe organ dysfunction, or other physical disabilities that lead to being bedbound or unable to perform foot care.
  • Patients with peripheral neuropathy caused by non-diabetic factors (e.g., toxic, nutritional, or hereditary neuropathies).
  • Patients with gestational diabetes or those with pre-existing diabetes who are currently pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes MellitusDiabetic Foot

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetic Neuropathies

Central Study Contacts

Chumin Zhang, Bachelor (Master student)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Data analysts are also blinded to the group assignments during the data analysis process.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study is a three-arm parallel randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Chief Nurse,Deputy Director of Nursing Department

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 12, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 12, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

The dataset contains sensitive clinical information and there is currently no formal plan for public data sharing.